Literature DB >> 1422379

Drug management of ulcerative colitis.

S Barrow, S H Rees.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1422379      PMCID： PMC1883475          DOI： 10.1136/bmj.305.6857.832

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  7 in total

1.  [Nephritis from 5-aminosalicylic acid].

Authors:  K E von Mühlendahl
Journal:  Dtsch Med Wochenschr       Date:  1989-02-10       Impact factor: 0.628

2.  Disposition of 5-aminosalicylic acid by olsalazine and three mesalazine preparations in patients with ulcerative colitis: comparison of intraluminal colonic concentrations, serum values, and urinary excretion.

Authors:  L Staerk Laursen; M Stokholm; K Bukhave; J Rask-Madsen; K Lauritsen
Journal:  Gut       Date:  1990-11       Impact factor: 23.059

3.  Topical and systemic availability of 5-aminosalicylate: comparisons of three controlled release preparations in man.

Authors:  L A Christensen; J Fallingborg; K Abildgaard; B A Jacobsen; G Sanchez; S H Hansen; S Bondesen; E F Hvidberg; S N Rasmussen
Journal:  Aliment Pharmacol Ther       Date:  1990-10       Impact factor: 8.171

4.  A pharmacokinetic study of sulphasalazine and two new formulations of mesalazine.

Authors:  G L Swift; C M Mills; J Rhodes; B K Evans; A Bennett; I A Tavares
Journal:  Aliment Pharmacol Ther       Date:  1992-04       Impact factor: 8.171

5.  Sulphasalazine induced renal failure.

Authors:  A D Dwarakanath; J Michael; R N Allan
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

6.  Comparison of the absorption and metabolism of sulphasalazine and acrylic-coated 5-amino salicylic acid in normal subjects and patients with colitis.

Authors:  M J Dew; P Ebden; N S Kidwai; G Lee; B K Evans; J Rhodes
Journal:  Br J Clin Pharmacol       Date:  1984-04       Impact factor: 4.335

7.  [Chronic inflammatory intestinal disease and nephritis].

Authors:  R Behrens; H Ruder
Journal:  Klin Padiatr       Date:  1992 Jan-Feb       Impact factor: 1.349
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.